About
Powered by Advanced and Clinically Tested Bioprinting Technologies PrintBio is deploying technologies utilized to manufacture and implant the first 3D-bioprinted living tissues in patients. PrintBio is the only clinical-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants. Leveraging first in human clinical experience, PrintBio is developing an array of products, beginning with 3DMatrix™, a 3D-printed monofilament bioresorbable surgical mesh (pending 510(k) FDA approval), utilizing its proprietary technologies clinically tested in patients.
Technologies
Outlook
WordPress.org
Google Font API
Google Tag Manager
Mobile Friendly
reCAPTCHA
Keywords
medical equipment manufacturing
biomaterial science
bioprinted organs
bioprinting for regenerative medicine
cell culture system
bioprinter
3d-bioprinting
medical devices
biomaterials
clinical-stage biotech
research and development in the physical
engineering
and life sciences
implantable devices
cell processes
custom-engineered implants
resorbable shell
bioprinting technology platform
biotechnology
bioprinted tissues
personalized organs
regenerative medicine
cgmp manufacturing
fda cleared products
bio-ink
biomedical engineering
therapeutic applications
microtia ear reconstruction
bioprinted tissue integrity
regulatory compliance
Company Information
-
Employees 4
-
Founded 2024
Location
51-36 35th St, New York, New York, United States, 11101
